LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Stryker Corp

Chiusa

SettoreSettore sanitario

376.43 2.06

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

365.04

Massimo

377.16

Metriche Chiave

By Trading Economics

Entrata

-10M

849M

Vendite

1.1B

7.2B

P/E

Media del settore

43.681

110.024

EPS

4.47

Rendimento da dividendi

0.93

Margine di Profitto

11.839

Dipendenti

56,000

EBITDA

351M

1.7B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+17.71% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.93%

2.26%

Utili prossimi

30 apr 2026

Prossima data del Dividendo

30 apr 2026

Prossima data del' Ex Dividendo

31 mar 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

3.6B

140B

Apertura precedente

374.37

Chiusura precedente

376.43

Notizie sul Sentiment di mercato

By Acuity

34%

66%

103 / 351 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stryker Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 gen 2026, 22:05 UTC

Utili

Stryker Logs Higher 4Q Profit On Sales Gains

30 ott 2025, 20:36 UTC

Utili

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31 lug 2025, 20:42 UTC

Utili

Stryker Lifts Guidance on Improving Tariff Outlook

1 mag 2025, 20:56 UTC

Utili

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

30 gen 2026, 17:03 UTC

Discorsi di Mercato

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 gen 2026, 21:07 UTC

Utili

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 gen 2026, 21:05 UTC

Utili

Stryker 4Q Adj EPS $4.47 >SYK

5 nov 2025, 19:38 UTC

Utili

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Utili

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 ott 2025, 20:21 UTC

Utili

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Adj EPS $3.19 >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q EPS $2.22 >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Sales $6.1B >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Net $859M >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Adj EPS $3.19 >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Net $859M >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Sales $6.06B >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q EPS $2.22 >SYK

31 lug 2025, 20:09 UTC

Utili

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 lug 2025, 20:09 UTC

Utili

Stryker Sales >SYK

31 lug 2025, 20:09 UTC

Utili

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q Sales $6B >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q Net $884M >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q EPS $2.29 >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q Adj EPS $3.13 >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q Sales $6B >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q EPS $2.29 >SYK

31 lug 2025, 20:05 UTC

Utili

Stryker 2Q EPS $2.29 >SYK

Confronto tra pari

Modifica del prezzo

Stryker Corp Previsione

Obiettivo di Prezzo

By TipRanks

17.71% in crescita

Previsioni per 12 mesi

Media 430.89 USD  17.71%

Alto 469 USD

Basso 387 USD

Basato su 19 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stryker Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

19 ratings

16

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

373.92 / 383.99Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

103 / 351 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat